Literature DB >> 4401216

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.

R Zacest, E Gilmore, J Koch-Weser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4401216     DOI: 10.1056/NEJM197203232861201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  48 in total

Review 1.  The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

2.  Effects of carvedilol on renal function.

Authors:  A G Dupont
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

4.  Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.

Authors:  R G Wilcox; J R Mitchell
Journal:  Br Med J       Date:  1977-08-27

5.  Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.

Authors:  M G Bianchetti; K Boehringer; P Weidmann; L Link; H Schiffl; W H Ziegler
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

6.  Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension.

Authors:  T Lüscher; J Havelka; P Greminger; J Tuma; M Täuber; W Siegenthaler; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Autoradiographic study of the distribution of [3H]- and [14C]-hydrallazine in the rat.

Authors:  J R Baker; G R Bullock; I H Williamson
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

Review 8.  Renal effects of antihypertensive drugs.

Authors:  W A Schlueter; D C Batlle
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

9.  Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil.

Authors:  K O'Malley; M Velasco; J Wells; J McNay
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

10.  Comparison of once and twice daily administration of sotalol in the treatment of hypertension.

Authors:  I Parvinen; E Paukkala
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.